Clinical trial · Interventional
Intraoperative Hyperspectral Imaging for Laparoscopic Surgery
Intraoperative Hyperspectral Imaging for Laparoscopic Surgery (LapHSI): a Multicentre Post-market Clinical Study
NCT06700317CI-TRIAL-00082821LapHSInot yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aims to evaluate the use of the HyperSnap Surgical System (HSS1) during laparoscopic surgeries, specifically in bowel resections and cholecystectomies.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cholecystectomy, Laparoscopic | — | UNRESOLVED | — |
| Cholecystitis | — | UNRESOLVED | — |
| Colorectal Neoplasms | Colorectal Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Colorectal Surgery | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| HSS1 | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- HSS1
- description
- Surgery performed using HSS1
- interventionNames
- Device: HSS1
Primary outcomes (1)
- measure
- Device safety
- timeFrame
- From enrollment to end of follow up (30 days)
- description
- To demonstrate that under normal conditions of use, the performance characteristics of the device are those intended, enabling laparoscopic abdominal surgery to be safely performed using the UKCA-marked medical device (HSS1) as the primary surgical visualisation system.
Secondary outcomes (4)
- measure
- Technological performance
- timeFrame
- Duration of surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: A) Cholelithiasis or cholecystitis with indications for laparoscopic surgery (cholecystectomy) * Adult patients aged 18 years and over * Common bile duct diameter \< 8mm as assessed using ultrasound * Patients able to provide written informed consent B) Colorectal cancer requiring elective bowel resection via a laparoscopic approach. * Adult patients aged 18 years and over * Patients who are scheduled for elective laparoscopic colon cancer resection * Patients able to provide written informed consent Exclusion Criteria: A) Cholelithiasis or cholecystitis with indications for laparoscopic surgery (cholecystectomy) * Patients under 18 years of age * Patients with a history of previous abdominal surgery and multiply scarred abdomen * Common bile duct diameter ≥ 8mm as assessed using ultrasound * Patients unable to provide written informed consent * Patients who are pregnant B) Colorectal cancer requiring elective bowel resection via a laparoscopic approach. * Patients under 18 years of age * Patients with a history of previous abdominal surgery and multiply scarred abdomen * Patients unable to provide written informed consent * Patients undergoing emergency surgery * Patients who are pregnant
References
Publications (0)
Data not yet available
No reference posted for this study.